These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 7937935
1. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Marks PA, Richon VM, Kiyokawa H, Rifkind RA. Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10251-4. PubMed ID: 7937935 [Abstract] [Full Text] [Related]
2. Induced differentiation, the cell cycle, and the treatment of cancer. Rifkind RA, Richon VM, Marks PA. Pharmacol Ther; 1996 Oct 25; 69(2):97-102. PubMed ID: 8984510 [Abstract] [Full Text] [Related]
3. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds. Marks PA, Richon VM, Rifkind RA. Int J Hematol; 1996 Jan 25; 63(1):1-17. PubMed ID: 8713572 [Abstract] [Full Text] [Related]
4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK, Medina D. Mol Carcinog; 1998 Jun 25; 22(2):128-43. PubMed ID: 9655257 [Abstract] [Full Text] [Related]
5. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5705-8. PubMed ID: 8650156 [Abstract] [Full Text] [Related]
6. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Richon VM, Rifkind RA, Marks PA. Cell Growth Differ; 1992 Jul 11; 3(7):413-20. PubMed ID: 1419904 [Abstract] [Full Text] [Related]
7. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6746-50. PubMed ID: 8341693 [Abstract] [Full Text] [Related]
8. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Baldassarre G, Barone MV, Belletti B, Sandomenico C, Bruni P, Spiezia S, Boccia A, Vento MT, Romano A, Pepe S, Fusco A, Viglietto G. Oncogene; 1999 Nov 04; 18(46):6241-51. PubMed ID: 10597222 [Abstract] [Full Text] [Related]
9. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA. Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091 [Abstract] [Full Text] [Related]
10. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells. Hyman T, Rothmann C, Heller A, Malik Z, Salzberg S. Exp Hematol; 2001 May 01; 29(5):563-71. PubMed ID: 11376868 [Abstract] [Full Text] [Related]
11. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells. Kiyokawa H, Ngo L, Kurosaki T, Rifkind RA, Marks PA. Cell Growth Differ; 1992 Jun 01; 3(6):377-83. PubMed ID: 1419901 [Abstract] [Full Text] [Related]
12. Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells. Marks PA, Rifkind RA. Environ Health Perspect; 1989 Mar 01; 80():181-8. PubMed ID: 2647479 [Abstract] [Full Text] [Related]
13. Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential. Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R. Proc Natl Acad Sci U S A; 1989 Aug 01; 86(16):6358-62. PubMed ID: 2762329 [Abstract] [Full Text] [Related]
14. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA. Prog Clin Biol Res; 1989 Aug 01; 316B():171-81. PubMed ID: 2616574 [Abstract] [Full Text] [Related]
15. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application. Marks PA, Rifkind RA. Int J Cell Cloning; 1988 Jul 01; 6(4):230-40. PubMed ID: 3047266 [Abstract] [Full Text] [Related]
16. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities. Aroor AR, Singh LP, Wahba AJ. Exp Hematol; 1995 Oct 01; 23(11):1204-11. PubMed ID: 7556531 [Abstract] [Full Text] [Related]
17. Growth inhibition and differentiation of C6 glioma cells on treatment with hmba. Shirsat NV, Kayal JJ, Shaikh S, Mehta A. Cell Biol Int; 2001 Oct 01; 25(7):621-7. PubMed ID: 11448101 [Abstract] [Full Text] [Related]
18. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells. Patterson KK, Beckman BS, Klotz DM, Mallia CM, Jeter JR. J Cancer Res Clin Oncol; 1996 Oct 01; 122(8):465-75. PubMed ID: 8698746 [Abstract] [Full Text] [Related]
19. Changes in E2F DNA-binding activity during induced erythroid differentiation. Richon VM, Venta-Perez G. Cell Growth Differ; 1996 Jan 01; 7(1):31-42. PubMed ID: 8788031 [Abstract] [Full Text] [Related]
20. Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Zhuo S, Fan S, Huang S, Kaufman S. Proc Natl Acad Sci U S A; 1995 May 09; 92(10):4234-8. PubMed ID: 7753788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]